Yoshiyuki Yabe

773 total citations
18 papers, 638 citations indexed

About

Yoshiyuki Yabe is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yoshiyuki Yabe has authored 18 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Yoshiyuki Yabe's work include Drug Transport and Resistance Mechanisms (3 papers), Cardiac Ischemia and Reperfusion (3 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Yoshiyuki Yabe is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cardiac Ischemia and Reperfusion (3 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Yoshiyuki Yabe collaborates with scholars based in Japan and United Kingdom. Yoshiyuki Yabe's co-authors include Makiya Nishikawa, Mitsuru Hashida, J. Brian Houston, Aleksandra Galetin, Yoshinobu Takakura, Fumiyoshi Yamashita, Mitsuru Hashida, Rei Takahashi, Naoki Kobayashi and Shigeru Kawakami and has published in prestigious journals such as FEBS Letters, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Yoshiyuki Yabe

17 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiyuki Yabe Japan 11 270 184 104 100 95 18 638
Martin Wurm Austria 12 364 1.3× 233 1.3× 76 0.7× 187 1.9× 82 0.9× 20 861
Steffen Frese Switzerland 17 544 2.0× 151 0.8× 80 0.8× 51 0.5× 29 0.3× 26 979
Lantu Gou China 20 547 2.0× 403 2.2× 93 0.9× 57 0.6× 152 1.6× 56 1.1k
Jeanne Féger France 19 544 2.0× 115 0.6× 73 0.7× 56 0.6× 89 0.9× 64 873
Ki Beom Bae South Korea 20 526 1.9× 309 1.7× 243 2.3× 79 0.8× 40 0.4× 69 1.2k
Jane Hamlett United Kingdom 14 274 1.0× 123 0.7× 41 0.4× 50 0.5× 42 0.4× 27 614
Zhao Tang China 14 269 1.0× 122 0.7× 41 0.4× 38 0.4× 22 0.2× 37 626
Du‐Shieng Chien United States 15 314 1.2× 148 0.8× 25 0.2× 34 0.3× 91 1.0× 22 783

Countries citing papers authored by Yoshiyuki Yabe

Since Specialization
Citations

This map shows the geographic impact of Yoshiyuki Yabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyuki Yabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyuki Yabe more than expected).

Fields of papers citing papers by Yoshiyuki Yabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiyuki Yabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyuki Yabe. The network helps show where Yoshiyuki Yabe may publish in the future.

Co-authorship network of co-authors of Yoshiyuki Yabe

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyuki Yabe. A scholar is included among the top collaborators of Yoshiyuki Yabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyuki Yabe. Yoshiyuki Yabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kita, Tomoko, Yoshiyuki Yabe, Yuki Maruyama, et al.. (2024). Pharmacokinetics of monoclonal antibodies locally-applied into the middle ear of guinea pigs. Hearing Research. 442. 108950–108950. 1 indexed citations
2.
Machinaga, Nobuo, Gary W. Ashley, Ralph R. Reid, et al.. (2018). A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules. Translational Vision Science & Technology. 7(4). 21–21. 10 indexed citations
3.
Ogitani, Yusuke, Yuki Abe, Takuma Iguchi, et al.. (2016). Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology. Bioorganic & Medicinal Chemistry Letters. 26(20). 5069–5072. 35 indexed citations
4.
Oitate, Masataka, Noriko Masubuchi, Takashi Ito, et al.. (2011). Prediction of Human Pharmacokinetics of Therapeutic Monoclonal Antibodies from Simple Allometry of Monkey Data. Drug Metabolism and Pharmacokinetics. 26(4). 423–430. 60 indexed citations
5.
Yabe, Yoshiyuki, Aleksandra Galetin, & J. Brian Houston. (2011). Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs. Drug Metabolism and Disposition. 39(10). 1808–1814. 109 indexed citations
6.
Yabe, Yoshiyuki, et al.. (2008). Applicability of DPI formulations for novel neurokinin receptor antagonist. International Journal of Pharmaceutics. 356(1-2). 102–109. 7 indexed citations
7.
Higuchi, Yuriko, Shigeru Kawakami, Machiko Oka, et al.. (2006). Intravenous administration of mannosylated cationic liposome/NFκB decoy complexes effectively prevent LPS‐induced cytokine production in a murine liver failure model. FEBS Letters. 580(15). 3706–3714. 32 indexed citations
8.
Kawakami, Shigeru, et al.. (2006). Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells. Journal of drug targeting. 14(8). 536–545. 30 indexed citations
9.
Saito, Yasunori, Shigeru Kawakami, Yoshiyuki Yabe, Fumiyoshi Yamashita, & Mitsuru Hashida. (2006). Intracellular Trafficking Is the Important Process That Determines the Optimal Charge Ratio on Transfection by Galactosylated Lipoplex in HepG2 Cells. Biological and Pharmaceutical Bulletin. 29(9). 1986–1990. 9 indexed citations
10.
Nishikawa, Makiya, et al.. (2006). Role of Tyrosine and Tryptophan in Chemically Modified Serum Albumin on Its Tissue Distribution. Biological and Pharmaceutical Bulletin. 29(9). 1926–1930. 2 indexed citations
11.
Nishikawa, Makiya, Kenji Hyoudou, Yuki Takahashi, et al.. (2004). Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clinical & Experimental Metastasis. 21(3). 213–221. 59 indexed citations
12.
Yabe, Yoshiyuki, Naoki Kobayashi, Makiya Nishikawa, et al.. (2002). Pharmacokinetics and Preventive Effects of Targeted Catalase Derivatives on Hydrogen Peroxide-Induced Injury in Perfused Rat Liver. Pharmaceutical Research. 19(12). 1815–1821. 20 indexed citations
13.
Takagi, Akira, Yoshiyuki Yabe, Yoshikazu Oka, Yoshinobu Takakura, & Mitsuru Hashida. (2002). Effect of Co-administration of Cationic Macromolecules on the In Vivo Disposition and In situ Renal Disposition Characteristics of rhIL-11. Drug Metabolism and Pharmacokinetics. 17(2). 136–141. 2 indexed citations
14.
Yabe, Yoshiyuki, et al.. (2001). Prevention of Neutrophil-Mediated Hepatic Ischemia/Reperfusion Injury by Superoxide Dismutase and Catalase Derivatives. Journal of Pharmacology and Experimental Therapeutics. 298(3). 894–899. 120 indexed citations
15.
Yabe, Yoshiyuki, et al.. (1999). Targeted Delivery and Improved Therapeutic Potential of Catalase by Chemical Modification: Combination with Superoxide Dismutase Derivatives. Journal of Pharmacology and Experimental Therapeutics. 289(2). 1176–1184. 98 indexed citations
16.
Yabe, Yoshiyuki, Yasuo Koyama, Makiya Nishikawa, Y Takakura, & Mitsuru Hashida. (1999). Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice. Free Radical Research. 30(4). 265–274. 36 indexed citations
17.
Takagi, Akira, et al.. (1997). Renal disposition of recombinant human interleukin-11 in the isolated perfused rat kidney.. Pharmaceutical Research. 14(1). 86–90. 7 indexed citations
18.
Ohwaki, Kazuhiro, et al.. (1972). Decrease in Cerebrospinal Fluid Pressure following the Pressure Injection Technique. Acta Radiologica Diagnosis. 13(P2). 599–611. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026